MLNR
ENSG00000102539
Target class
GPCR
Chromosome
13
Approved drugs
0
Clinical candidates (approved and in development)
4
- Approved drugs
- 0
- Clinical candidates (approved and in development)
- 4
- Chemical probe available
- No
- Target name
- MLNR
- Gene name
- Motilin receptor
- Gene symbol
- MLNR
- Previous gene symbols
- GPR38
- Protein name
- Motilin receptor (G-protein coupled receptor 38)
- Gene biotype
- Protein coding
- Gene family
- Peptide receptors
- Target class
- GPCR
- Target type
- Human gene
- Tissues expressed in
- 0
- Protein localisation evidence grade
- Approved
- Highest tissue expression
- 0.41
- Tissue specificity (Gini)
- 0.534
- Tissue specificity (tau)
- 0.859
- KEGG gene identifiers
- hsa:2862
- Protein interaction confidence
- 0.866333
- Protein interaction partners
- 3
- R-HSA-375276
- R-HSA-416476
- End position
- 49225201
- Start position
- 49220118
- Chromosome
- 13
- Strand
- Forward
- Cell membrane
- Multi-pass membrane protein.
- Plasma membrane
- Tissue specificity (tau)
- 0.858721
- Expression inequality (Gini)
- 0.533951
Expression in transcripts per million
- Thyroid
- 0.41
- Testis
- 0.37
- Stomach
- 0.23
- Pituitary
- 0.21
- Cervix - Endocervix
- 0.18
Expression in transcripts per million
- Thyroid0.41
- Testis0.37
- Stomach0.23
- Pituitary0.21
- Cervix - Endocervix0.18
- Nerve - Tibial0.15
- Esophagus - Gastroesophageal Junction0.11
- Cervix - Ectocervix0.11
- Colon - Sigmoid0.09
- Whole Blood0.09
- Fallopian Tube0.08
- Kidney - Medulla0.08
- Esophagus - Muscularis0.07
- Prostate0.07
- Bladder0.07
- Ovary0.07
- Brain - Hypothalamus0.06
- Uterus0.06
- Lung0.05
- Vagina0.05
- Adrenal Gland0.05
- Brain - Amygdala0.04
- Spleen0.04
- Cells - Cultured fibroblasts0.04
- Brain - Spinal cord (cervical c-1)0.04
And 29 more, listed on the interactive page.
Cellular components
- GO:0005886
- GO:0005515
- GO:0008528
- GO:0042562
Related records
Trials (620)
- "Performance of HPV DNA Test in Presence of Co-infection With Common RTIs"
- A Bioequivalence Study of Two Azithromycin Tablet Formulations in Indonesian Healthy Subjects
- A Comparative Study of Azithromycin and S-P as Prophylaxis in Pregnant HIV+ Patients
- A Comparative Study on Ivermectin and Hydroxychloroquine on the COVID19 Patients in Bangladesh
- A Comparison of Safety and Efficacy of Cefdinir Oral Suspension Versus Azithromycin in Pediatric Subjects With Acute Otitis Media
- A Four Week Study of Azithromycin Ophthalmic Solution, 1% Versus Placebo in Subjects With Dry Eye Disease
- A Four Week Study of Azithromycin Ophthalmic Solution, 1% Versus Rewetting Drops in Subjects With History and Current Complaint of Contact Lens-Related Dry Eye (CLDE)
- A Four Week Study of Azithromycin Ophthalmic Solution, 1% Versus Vehicle in Subjects With Blepharitis (P08636)
- A Four Week, Open-Label Study of Azithromycin Ophthalmic Solution, 1% (P08641)
- A Multicenter, Randomized, Double-Blind, Double-Dummy Comparative Trial of Azithromycin Sustained Release Versus 3-Day Azithromycin for the Treatment of Strep Throat in Adolescents and Adults
- A Multicenter, Randomized, Double-Blind, Double-Dummy Study Of Azithromycin SR Versus Amoxicillin For The Treatment Of Strep Throat In Children
- A Multicenter, Randomized, Double-Blind, Double-Dummy Trial of Azithromycin SR Compared With Clarithromycin Extended Release for the Treatment of Pneumonia in Adult Patients
- A Multicenter, Randomized, Double-Blind, Double-Dummy Trial of Azithromycin SR Compared With Levofloxacin for the Treatment of Acute Symptoms of Chronic Bronchitis
- A Multicenter, Randomized, Double-Blind, Double-Dummy Trial of Azithromycin SR Compared With Levofloxacin for the Treatment of Mild to Moderate Pneumonia in Adult Patients
- A Multicenter, Randomized, Double-Blind, Double-Dummy Trial of Azithromycin SR Compared With Levofloxacin for the Treatment of Sinus Infections in Adults
- A Multicentre Open-label Two-arm Randomised Superiority Clinical Trial of Azithromycin Versus Usual Care In Ambulatory COVID19 (ATOMIC2)
- A Multicentre, Randomised, Open-Label Study To Compare The Efficacy And Safety Of Azithromycin For 5 Days With Those Of Amoxicillin-Clavulanic Acid In Patients With Chronic Bronchitis
- A P3 Comparator Trial in Community Acquired Bacterial Pneumonia
- A Pediatric Taste Test Study of Omnicef Versus Zithromax Antibiotic Suspension Medications
- A Phase 1 Study To Estimate The Relative Bioavailability Of Co-Administered Formulations Of Azithromycin Microsphere And Chloroquine Test Formulation Compared With Co-Administered Immediate Release Individual Azithromycin And Chloroquine Tablets In Healthy Adult Subjects
Drugs (8)
- Alemcinal
- Atilmotin Motilin receptor agonist
- Azithromycin
- Camicinal Motilin receptor agonist
- Erythromycin
- Mitemcinal Motilin receptor agonist
- Mitemcinal fumarate Motilin receptor agonist
- Roxithromycin